The government is in talks with Johnson & Johnson regarding their single-dose vaccine and as per the plan, this vaccine will also be produced by Hyderabad's Biological E, NITI Aayog member-health Dr V K Paul said. The vaccine has shown strong neutralising antibody activity against the Delta (B16172) variant, with immunity lasting at least eight months, according to results of pre-print phase-III trials.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3hcXaqb
कोई टिप्पणी नहीं:
एक टिप्पणी भेजें